Urology Flashcards
Function of the Urinary Tract
To collect urine produced continuously by the kidneys
To store collected urine safely
To expel urine when socially acceptable
Anatomy of kidney
Retroperitoneal organs
Lie between T11 – L3
Blood supply from renal artery direct from aorta at L1 level
How many nephrons does each kidney contain
1 million nephrons
How much urine does each kidney produce a day
1-1.5L of urine per day
Ureters- Anatomy
25cm – 30cm
Retroperitoneal organs
Run over psoas muscle, cross the iliac vessels at the pelvic brim and insert into trigone of bladder
Ureters function
Transport urine from the kidney to the bladder via peristalsis
What is preventing the reflex of urine
a valvular mechanism at the vesicoureteric junction
Nervous Control of the Bladder and Sphincter- 4 nerve
Parasympathetic Nerve (pelvic nerve)
Sympathetic Nerves (hypogastric plexus)
Somatic Nerve (pudendal nerve)
Afferent pelvic nerve
Nervous Control of the Bladder and Sphincter- Parasympathetic Nerve (pelvic nerve)
- S2-S4
- acetylcholine neurotransmitter
- involuntary control
Nervous Control of the Bladder and Sphincter- Sympathetic Nerves (hypogastric plexus)
T11 – L2
noradrenaline neurotransmitter
involuntary control
Nervous Control of the Bladder and Sphincter- Somatic Nerve (pudendal nerve)
S2-S4
“Onuf’s nucleus”
acetylcholine neurotransmitter
Nervous Control of the Bladder and Sphincter- Afferent pelvic nerve
Sensory nerve
signals from detrusor muscle
Neural Control- Onuf’s Nucleus
Responsible for guarding reflex
Neural Control- Pontine Micturition Centre/Periaqueductal Grey
Responsible for Co-ordination of voiding
Neural Control- Cortex
Responsible for voluntary control
Neural Control- Sacral Micturition Centre
Responsible for Micturition reflex
Storage Phase
Bladder fills continuously
As the volume in the bladder increases the pressure remains low due to “receptive relaxation” and detrusor muscle compliance
Filling Phase
At lower volumes the afferent pelvic nerve sends slow firing signals to the pons via the spinal cord
Filling phase- nerves
-Sympathetic nerve (hypogastric plexus) stimulation maintains detrusor muscle relaxation
-Somatic (Pudendal) nerve stimulation maintains urethral contraction
Voiding Phase – Micturition Reflex
Autonomic spinal reflex
Higher volumes stimulate the afferent pelvic nerve to send fast signals to the sacral micturition centre in the sacral spinal cord
Voiding Phase – Micturition Reflex- nerves
Pelvic parasympathetic nerve is stimulated and the detrusor muscle contracts
Pudendal nerve is inhibited and the external sphincter relaxes
Guarding Reflex
Voluntary control of micturition
Guarding Reflex
Afferent signals from the pelvic nerve are received by the PMC/PAG and transmitted to higher cortical centres
If voiding is inappropriate the guarding reflex occurs
Sympathetic (hypogastric) nerve stimulation results in detrusor relaxation
Pudendal nerve stimulation results in contraction of the external urethral sphincter
Storage summary
Receptive Relaxation
Detrusor relaxation (sympathetic stimulation T11-L2)
External Urethral Sphincter contracted (pudendal stimulation S2-4)
Micturition
Voluntary control from cortex and PMC
Detrusor contraction (parasympathetic stimulation S2-4)
External Urethral Sphincter relaxation (pudendal inhibition S2-4)
Penile cancer epidemiology
Rare in UK, more common in far east and Africa
Very rare in circumcised
Related to smegma, chronic inflammation and viruses
Penile cancer presentation
Chronic fungating ulcer, bloody/purulent discharge
50% spread to lymph at presentation
Penile cancer treatment
Radiotherapy and iridium wires (protons instead of x-ray radiation) if early
Amputation and lymph node dissection if late
Benign diseases of the penis
Balanitis, Phimosis, Paraphimosis
Balanitis
Acute inflammation of the foreskin and glans
Association with strep and strap infections
More common in diabetes and young children with tight foreskins
Balanitis- treatment
Antibiotics, circumcision, hygiene advice
Phimosis
Foreskin occludes the meatus (hole where fluids leave body)
Young boys- recurrent balanitis + ballooning, may heal with time or require circumcision
Adult- presents with painful intercourse, infection, ulceration
Paraphimosis treatment
Ask patient to squeeze glans
Try applying 50% glucose-soaked swab (oedema may follow osmotic gradient), ice packs and lidocaine gel may help
May require aspiration, dorsal slit, circumcision
Paraphimosis
Occurs when tight foreskin is retracted and becomes irreplaceable, preventing to venous return leading to oedema and even ischemia of the glans
Can occur if the foreskin is not replaced after catheterization
Impotence
Erectile dysfunction
Common in over 50s
Physiological facet is common
Normal erection function
Results from neuronal release of NO which, via cGMP and Ca2+, hyperpolarizes and thus relaxes vascular and trabecular smooth muscle cells, allowing engorgement
Impotence causes
Physiological
Organic- Big 3- smoking, alcohol + diabetes
- Endocrine, neurological, pelvic surgery, radiotherapy, atheroma, renal/ hepatic failure, prostatic hyperplasia, penile abnormalities, drugs
Impotence investigations
Full sexual and physiological work up
Bloods- U+E, LFTs, glucose, TFT, LH, FSH, lipids, testosterone, prolactin
Doppler test (US to see how blood flows in the penis during and after an erection)
Impotence treatment
Treat underlying causes
Counselling
Oral phosphodiesterase inhibitors (increase cGMP)
Bladder tumours
In the UK >90% are transitional cell carcinomas
Adenocarcinomas and squamous cell carcinomas are rare in west
More common in men then women
Bladder tumours- grading
Grade 1- differentiated
Grade 2- intermediate
Grade 3- poorly differentiated
Bladder tumours- location
80% confined to bladder mucosa
20% penetrate muscle (worse prognosis)
Bladder tumour- presentation
Painless haematuria (blood in urine), recurrent UTIs, voiding irritability
Bladder tumour- associations
Smoking, aromatic amines (rubber industry), chronic cystitis schistosomiasis, pelvic irradiation
Bladder tumour- investigations
Cystoscopy with biopsy is diagnostic
CT urogram is diagnostic (provides staging)
Urine- microscopy/cytology
MRI/ lymphangiography may show involved nodes
Bladder tumour- staging Tis
Carcinoma in situ
Bladder tumour- staging Ta
Tumour confined to epithelium
Bladder tumour- staging T2
Invades muscle
Bladder tumour- staging T1
Tumour in submucosa or lamina propira
Bladder tumour- staging T3
Extends to perivesical fat
Bladder tumour- staging T4
Invades adjacent organs
Bladder tumour- staging N0-N4
N0- no lymph node involvement
N1-N4 progressive lymph node involvement
Bladder tumour- staging M0/M1
M0- no mets
M1- distant mets
Treatment of transitional cell carcinomas (TCC) of the bladder- Tis/Ta/T1
80% of all patients
Diathermy (deep heating) via transurethral cystoscopy or TURBT (transurethral resection of bladder tumour)
Consider intravesical BCG (stimulates a non specific immune response)
Treatment of transitional cell carcinomas (TCC) of the bladder- T2-3
Radical cystectomy (removal of bladder) is gold standard
Radiotherapy gives worse survival rates but preserves the bladder
Post-op chemo toxic but effective
Trying other surgical methods to preserve the bladder, but none are effective yet
Treatment of transitional cell carcinomas (TCC) of the bladder- T4
Usually palliative chemo/radiotherapy
Chronic catheterization and urinary diversions may help relive pain
What to use to measure chronic disease
eGFR and ACR (albumin to creatinine ratio)
Chronic kidney disease- prevalence in UK
4.19%, large differences in areas due to difference in age, health inequality
Most common cause of end stage kidney disease in the UK
Diabetes (diabetic neuropathy)
Other common causes- hypertension, glomerulonephritis, secondary to pre-eclampsia
Blood pressure control in CKD
High protein in urine= lower BP threshold for hypertension intervention
ACEi/ARBs are first line
Diabetic Nephropathy in CKD
Hyperglycaemia leads to increase in growth factors, RAAS activation and oxidative stress. This causes increase in glomerular capillary pressure, podocyte damage and endothelial dysfunction.
Albuminuria is 1st clinical sign, later scarring (glomerulosclerosis), nodule formation, and fibrosis with progressive loss of renal function ie CKD
Anaemia in CKD
Common as EPO is produced in peritubular cells of the kidney, when kidneys are damaged, EPO production reduces
Less EPO, less RBC production, less O2
Fluid overload in CKD
Progressive loss of renal function causes reduced sodium filtration and inappropriate suppression of tubular reabsorption that ultimately lead to volume expansion
Sodium in CKD
Sodium accumulation is one of the consequences of renal failure, resulting in increased water intake, increases in the extracellular volume, and accompanying rise in blood pressure
Most common cause of death with CKD
Cardiovascular events
Glomerulonephritis in CKD
inflammation of the glomeruli. Severe or prolonged inflammation associated with glomerulonephritis can damage the kidneys causing CKD
SGLT2 inhibitors in CKD
effective at slowing the progression of kidney disease, reducing heart failure, and lowering the risk of kidney failure and death in people with CKD and type 2 diabetes
Bone mineral disorders in CKD
Damaged kidneys stop
-turning vitamin D into calcitriol, creating an imbalance of Ca2+ in your blood
-removing excess phosphorus from your blood, triggering your blood to pull Ca2+ out of your bones and causing them to weaken
-release extra PTH, Ca2+ from your bones to restore your blood calcium levels
Who gets renal cancer?
Hypertension, obesity, smoking- (oxidative stress)
Other renal cancer RF
family history (5%- VHL usually)
ESRF
Tuberous sclerosis
Renal cancer investigation
Flank pain, palpable mass, blood in urine- classic trifecta
Imaging- CT, MRI
Horse shoe kidney
a condition in which the kidneys are fused together at the lower end or base
Haematuria and 2 week wait guidance
Visible Haematuria, over 45%, 30% risk of cancer
Non-visible haematuria, over 60, 5% risk of cancer
Cannonball metastases
Classic feature of metastatic renal cell carcinoma, appears as clearly defined circular opacites scattered throughout the lung
Most common renal cancer type
Clear cell renal carcinoma
Others- papillary and chromophobe carcinomas
Treatment options for renal cancer- surgical
Radical/partial nephrectomy, to remove tumour is first line
Treatment options for renal cancer- non invasive
Arterial embolisation- cutting off the blood supply to the affected kidney
Percutaneous cryotherapy- injecting liquid nitrogen to freeze and kill the tumour cells
Radiofrequency ablation- putting a needle in the tumour and using an electrical current to kill the tumour cells
GFR influenced by
Net Filtration Pressure (NFP)- Hydrostatic pressures + Colloid osmotic pressures
Renal Blood Flow (RBF)- Autoregulation
Filtration coefficient
4 starling forces effecting net fluid movement
Glomerular hydrostatic pressure- fluid out
Bowman’s Capsule fluid pressure- fluid in
Glomerular colloid osmotic pressure
(pi*G; protein)- fluid in
Bowman’s Capsule colloid osmotic pressure- should be negligible as albumen is filtered out
Net Filtration Pressure (NFP) =
Glomerular hydrostatic pressure - (Bowman’s Capsule fluid pressure + Glomerular colloid osmotic pressure)
Renal Auto-regulation
Intrinsic feedback mechanisms
-Afferent and efferent arterioles
-Tubuloglomerular Feedback
Why is creatine used to measure eGFR
Production rate is roughly similar to clearance rate in the body
GFR equation
urine flow rate * [creatine] urine] / [creatine] plasma
Problems with eGFR
Doesn’t consider creatinine tubular secretion
Significant decrease GFR small [Cr] plasma- Need several time points
Creatinine metabolism reflection on lean body mass
Not valid in pregnancy
DAMN drugs
Induce, exacerbate or complicate AKI: acidosis, hypovolaemia or hypertension
DAMN drugs- acronym meaning
Diuretics
ACEis/ARB
Metformin
NSAIDs
Factors that Decrease GFR
Increase Afferent artery resistance- NSAIDs
Decrease efferent artery resistance, decrease angiotensin II (ACEi/ARB)
Increase Glomerular colloid osmotic pressure- decrease renal BF, increase plasma proteins
Increase bowmens c
Factors that Decrease GFR- increase Afferent artery resistance
NSAIDs
Factors that Decrease GFR- decrease Efferent artery resistance
Due to decrease Angiotensin II ie ACEi/ARB
Factors that Decrease GFR- increase Glomerular colloid osmotic pressure
Decrease in renal BF, increase in plasma protein
Factors that Decrease GFR- increase Bowmen capsule fluid pressure
Urinary tract obstruction (kidney stones)
Factors that Decrease GFR- decrease kidney function
Renal disease Diabetes mellitus Hypertension
Factors that Decrease GFR- decrease Glomerular hydrostatic pressure
Decrease Arterial pressure (small effect)
Which ion has a key role in determining plasma volume and osmolality?
Na+
Expansion of Fluid Volume - A Simple System
Increase Blood volume
Increase BP
Increase renal excretion
Normal vol restored
Regulation of Blood Pressure and Volume
Baroreceptor reflexes (medulla)- measure BP
Osmoreceptor Reflexes (hypothalamus)- measure Na+
Pressure Natriuresis and Atrial Natriuretic Peptide (ANP)
ANP generally antagonises Angiotensin-II actions
- inhibits renin secretion
-afferent arteriole dilation
Benign prostatic hyperplasia- epidemiology
Very common
24% for 40-64
40% for 64+
Benign prostatic hyperplasia- pathology
Benign nodular or diffuse proliferation of musculofibrous and glandular layers
Inner (transitional) zone enlarges
Benign prostatic hyperplasia vs prostate carcinoma- pathology
Benign prostatic hyperplasia- Inner (transitional) zone enlarges
Prostate carcinoma- enlargement of peripheral layers of the prostate
Benign prostatic hyperplasia- presentation
LUTS (lower urinary tract symptoms)
LUTS (lower urinary tract symptoms)
Nocturia, frequency, urgency, post-micturition dribbling, poor stream/flow, hesitancy, overflow incontinence, haematuria, bladder stones, UTIs
Benign prostatic hyperplasia- tests
MSU (Midstream Specimen of Urine), U+Es, Ultrasound, PSA (prostate-specific antigen), transrectal ultrasound +/- biopsy
PSA (prostate-specific antigen)
A protein produced by both cancerous and noncancerous tissue in the prostate
Benign prostatic hyperplasia- lifestyle management
Avoid alcohol, caffeine
Relax when voiding, void twice to aid emptying
Train bladder by practising distraction methods and holding on
Benign prostatic hyperplasia- drug management
Alpha-blockers are 1st line (decrease smooth muscle tone)
5 alpha-reductase inhibitors- shrink the prostate gland if it’s enlarged, can be used alone or in combination
Benign prostatic hyperplasia- surgical indications
Have complications attributed to BPH, such as acute and/or chronic renal insufficiency, recurrent bladder stones, gross recurrent haematuria, recurrent UTIs
Have refractory responses to medication
Benign prostatic hyperplasia- surgical management
Transurethral resection of the prostate (TURP)- historical standard
Other options- Simple prostatectomy, Transurethral vaporisation of the prostate (TUVP)
Glomerulonephritis
Group of diseases that cause inflammation and damage to glomeruli
May be acute or chronic
Glomerulonephritis Signs/symptoms
Declining renal function
Hypertension
Leaky glomerulus- haematuria, proteinuria
Glomerulonephritis Progression
Causes 25% of ESKF
Glomerulonephritis Pathophysiology
Glomerulonephritis is usually immunologically mediated:
-Immunoglobulin deposits
-Inflammatory cells
-Response to immunosuppressive therapy
Acute Nephritic syndrome- characteristics
Acute kidney injury, active dipstick (haematuria and proteinuria), Oliguria, hypertension and fluid overload
Acute Nephritic syndrome- immune mediated examples
ANCA associated vasculitis
Goodpasture’s disease, SLE (systemic lupus erythematosus), systemic sclerosis, post-streptococcal infection, Crescentic IgA nephropathy, Henoch Schonlein purpura (HSP)
Acute Nephritic syndrome - Urine
Haematuria key feature- red ell casts on urine microscopy characteristic of glomerular bleeding
Proteinuria is variable but usually sub-nephrotic levels